CLINICAL RELEVANCE: DRUG–DRUG INTERACTION,PHARMACOKINETICS,PHARMACODYNAMICS, AND TOXICITY - Drug Transporters: Molecular Characterization and Role in Drug Disposition - page 874

881. Wang J, Su SF, Dresser MJ, Schaner ME, Washington CB, Giacomini KM. 1997. Na + -
dependent purine nucleoside transporter from human kidney: cloning and functional
characterization. Am J Physiol 273: F1058-F1065.
882. Graham KA, Leithoff J, Coe IR, Mowles D, Mackey JR, Young JD, Cass CE. 2000.
Differential transport of cytosine-containing nucleosides by recombinant human
concentrative nucleoside transporter protein hCNT1. Nucleosides Nucleotides Nucleic
Acids 19: 415-434.
883. Lostao MP, Mata JF, Larrayoz IM, Inzillo SM, Casado FJ, Pastor-Anglada M. 2000. Elec-
trogenic uptake of nucleosides and nucleoside-derived drugs by the human nucleoside
transporter 1 (hCNT1) expressed in Xenopus laevis oocytes. FEBS Lett 481: 137-140.
884. Mata JF, Garcia-Manteiga JM, Lostao MP, Fernandez-Veledo S, Guillen-Gomez E,
Larrayoz IM, Lloberas J, Casado FJ, Pastor-Anglada M. 2001. Role of the human
concentrative nucleoside transporter (hCNT1) in the cytotoxic action of 5 -deoxy-5-
fluorouridine, an active intermediate metabolite of capecitabine, a novel oral anticancer
drug. Mol Pharmacol 59: 1542-1548.
885. Wang J, Schaner ME, Thomassen S, Su SF, Piquette-Miller M, Giacomini KM. 1997.
Functional and molecular characteristics of Na( + )-dependent nucleoside transporters.
Pharm Res 14: 1524-1532.
886. Schaner ME, Wang J, Zhang L, Su SF, Gerstin KM, Giaomini KM. 1999. Functional
characterization of a human purine-selective, Na + -dependent nucleoside transporter
(hSPNT1) in a mammalian expression system. J Pharmacol Exp Ther 289: 1487-
1491.
887. Patil SD, Ngo LY, Glue P, Unadkat JD. 1998. Intestinal absorption of ribavirin is preferen-
tially mediated by the Na + nucleoside purine (N1) transporter. Pharm Res 15: 950-952.
888. Gerstin KM, Dresser MJ, Giacomini KM. 2002. Specificity of human and rat orthologs
of the concentrative nucleoside transporter, SPNT. Am J Physiol Renal Physiol 283:
F344-F349.
889. Ritzel MW, Ng AM, Yao SY, Graham K, Loewen SK, Smith KM, Ritzel G, Mowles
DA, Carpenter P, Chen XZ, et al. 2001. Molecular identification and characterization of
novel human and mouse concentrative Na

+

-nucleoside cotransporter proteins (hCNT3
and mCNT3) broadly selective for purine and pyrimidine nucleosides. J Biol Chem 276:
2914-2927.
890. Hu H, Endres CJ, Chang C, Umapathy NS, Lee EW, Fei YJ, Itagaki S, Swaan PW,
Ganapathy V, Unadkat JD. 2006. Electrophysiological characterization and modeling of
the structure activity relationship of the human concentrative nucleoside transporter 3
(hCNT3). Mol Pharmacol 69: 1542-1553.
891. Toan SV, To KK, Leung GP, de Souza MO, Ward JL, Tse CM. 2003. Genomic
organization and functional characterization of the human concentrative nucleoside
transporter-3 isoform (hCNT3) expressed in mammalian cells. Pflugers Arch 447: 195-
204.
892. Baldwin SA, Mackey JR, Cass CE, Young JD. 1999. Nucleoside transporters: molecular
biology and implications for therapeutic development. Mol Med Today 5: 216-224.
893. Griffiths M, Beaumont N, Yao SY, Sundaram M, Boumah CE, Davies A, Kwong
FYP, Coe I, Cass CE, Young JD, Baldwin SA. 1997. Cloning of a human nucleoside
transporter implicated in the cellular uptake of adenosine and chemotherapeutic drugs.
Nat Med 3: 89-93.